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Documento de Consenso sobre la prevención, 
diagnóstico y tratamiento de las infecciones 
por catéter venoso periférico en adultos
RESUMEN 
El uso de catéteres vasculares es una práctica muy utiliza-
da en los hospitales. El uso de catéteres venosos periféricos de 
corta duración se ha asociado con un elevado riesgo de bacte-
riemia nosocomial, lo que comporta una no despreciable mor-
bilidad y mortalidad. La etiología de estas infecciones suele ser 
frecuentemente por Staphylococcus aureus, lo que explica su 
gravedad. En este documento de consenso, elaborado por un 
panel de expertos de La Sociedad Española de Infecciones Car-
diovasculares con la colaboración de expertos de la Sociedad 
Española de Medicina Interna, La Sociedad Española de Qui-
mioterapia y la Sociedad Española de Cirugía Torácica y Car-
diovascular, pretende establecer unes normes para un mejor 
uso de los catéteres venosos periféricos de corta duración. El 
Documento revisa las indicaciones para su inserción, manten-
imiento, registro, diagnóstico y tratamiento de las infecciones 
derivadas y las indicaciones para su retirada; haciendo énfasis 
en la formación continuada del personal sanitario para lograr 
una mayor calidad asistencial. Seguir las recomendaciones del 
consenso permitirá utilizar de una manera más homogénea los 
catéteres venosos periféricos minimizando el riesgo de infec-
ción y sus complicaciones.
Palabras Clave: Infección de catéter; catéter venoso periférico; bacter-
iemia, prevención de la infección de catéter; diagnóstico de la infección de 
catéter; tratamiento de la infección de catéter, infección nosocomial
ABSTRACT
The use of endovascular catheters is a routine practice in 
secondary and tertiary care level hospitals. Short peripheral 
catheters have been found to be associated with the risk of 
nosocomial bacteremia resulting in morbidity and mortality. 
Staphyloccus aureus is mostly associated with peripheral cath-
eter insertion. This Consensus Document has been elaborated 
by a panel of experts of the Spanish Society of Cardiovascular 
Infections in cooperation with experts from the Spanish So-
ciety of Internal Medicine, Spanish Society of Chemotherapy 
and Spanish Society of Thoracic-Cardiovascular Surgery and 
aims at define and establish the norm for management of 
short duration peripheral vascular catheters. The document 
addresses the indications for insertion, catheter maintenance 
and registry, diagnosis and treatment of infection, indications 
for removal and stresses on continuous education as a driver 
for quality. Implementation of this norm will allow uniformity 
in usage thus minimizing the risk of infection and its compli-
cations.
Key words: catheter infection, peripheral venous catheter, bacteremia, 
prevention of catheter infection, diagnosis of catheter infection, 
treatment of catheter infection, nosocomial infection
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PARTICIPATING ORGANIZATIONS
This Consensus Document has been elaborated by a panel 
of experts of the Spanish Society of Cardiovascular Infections 
(SEICAV) in cooperation with experts from the following sci-
entific societies: Spanish Society of Internal Medicine (SEMI), 
Spanish Society of Chemotherapy (SEQ) and Spanish Society of 
Thoracic-Cardiovascular Surgery (SECTCV).
METHODS
The recommendations for insertion, handling and removal 
of PVCs and also what to do when suspecting infection (di-
agnosis) and its treatment are issued based on the best sci-
entific available evidence or, when not available, on expert 
opinion. Therefore, PubMed (www.PubMed.org) literature 
search between 1986 and 2015 has been performed. This is a 
well-known free access resource established and maintained 
by the National Center for Biotechnology Information (NCBI) 
of the National Library of Medicine (NLM) of the USA, which 
provides free access to MEDLINE, the database of citations and 
abstracts of the NLM. It currently stores over 24 million cita-
tions from over 5,600 biomedical journals. 
In our PubMed search using the Medical Subject Head-
ings (MeSH) terms “management of peripheral venous catheter” 
(N=363) and “peripheral catheter-related bacteremia” (N=260), 
studies related to newborns or pediatric patients and studies on 
peripherally inserted central catheters (PICC) were discarded. MeSH 
terms is the NLM controlled vocabulary thesaurus used for indexing 
articles for PubMed (www.pubmed.org). Guidelines on prevention, 
diagnosis and treatment of catheter infection were reviewed7-10.
The levels of evidence and strength of recommendations 
according to the below definitions will be shown in bold within 
brackets when a recommendation is made in the text.
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BACKGROUND
The use of endovascular catheters is generalized practice 
in the hospital setting1. A recent prevalence study showed that 
81.9% of patients admitted to Internal Medicine services are 
inserted with one or more catheters, out of which 95.4% are 
short duration peripheral lines2. It has also recently been doc-
umented the increasing influence of peripheral catheters as a 
driver for nosocomial bacteremia with high associated morbid-
ity and mortality3-5. Several studies have shown that the risk 
of bacteremia related to a peripheral venous catheter (PVC) is 
similar to that of central venous lines6 with an estimate of 0 
to 5 bacteremia episodes per 1000 catheter-days in admitted 
adult patients4,6. Furthermore, the vast majority of cases of 
PVC-related bacteremia are S. aureus bacteremia; this is dif-
ferent from central venous lines, being S. epidermidis the most 
frequent isolated pathogen in the latter setting3,4. This yields 
a higher complication rate including nosocomial endocarditis 
thus making treatment difficult. There are several guidelines 
and consensus documents on prevention, diagnosis and treat-
ment of central venous catheter-related infections7-10 that 
have greatly contributed to reduce the infection rate and facil-
itate its management, especially in Intensive Care Units (ICU). 
However, there is scanty literature focusing on short duration 
peripheral catheters which are those mostly used out of the 
ICU setting1,11. Several observational studies have shown that 
there is lack of knowledge on how to use PVC by the attending 
staff12 and on the opportunities to improve its handling1,12-14.
OBJECTIVE
The objective of this Consensus Document is to review ev-
idence and make recommendations for management of short 
duration PVC in adults. This will allow uniformity in usage thus 
minimizing the risk of infection and its complications.
Table 1  Infectious Disease Society of America–United States Public Health Service Grading System for ranking 
recommendations in clinical guidelines15.
Category, Grade  Definition
Strength of recommendation
A  Good evidence to support a recommendation for use
B  Moderate evidence to support a recommendation for use
C Poor evidence to support a recommendation
D Moderate evidence to support a recommendation against use
E  Good evidence to support a recommendation against use
Quality of evidence
I Evidence from >1 properly randomized, controlled trial
II  Evidence from >1 well-designed clinical trial, without randomization; from cohort or case-controlled analytic stu-
dies (preferably from >1 center); from multiple time-series; or from dramatic results from uncontrolled experiments
III  Evidence from opinions of respected authorities, based on clinical experience, descriptive studies, or reports of ex-
pert committees
hanced asepsis is not required if the endovenous segment of the 
PVC is not manipulated9 (III-B). As it is the case when inserting 
central venous lines, the use of additional protection measures 
like facemask is not recommended. However, this is a topic for 
consideration and analysis if in a given institution higher than 
expected rates of PVC-related bacteremia are observed.
Sterile gauze dressing or semi permeable transparent sterile 
dressing to cover the insertion site will be used23,24 (II-A). Ster-
ile gauze dressing will be inspected and replaced every other day 
and transparent dressing should not stay in place over 7 days9. If 
there is humidity, sweating or blood it is more appropriate to use 
non-occlusive gauze dressing24,25 (III-B). Revision or replacement 
of dressing must be performed with single-use clean gloves9.
PVCs placed on urgent basis or without considering min-
imal hygiene rules must be removed and replaced before 48 
hours to avoid the risk of infection17,26,27 (II-A).
The use of techniques facilitating identification of veins as 
laser or ultrasound28,29 in patients with poor venous flow are 
also recommended for insertion. However, these techniques do 
not reduce the risk of infection. A meta-analysis on this topic 
showed that its routine use is not justified30 (I-A).
4. Checklist
The adhesion to recommendations in the form of check-
list is associated to better results in prevention of post-inser-
tion complications after insertion of central venous lines and 
PVCs10,31 (I-A). This is reflected in table 2.
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DEFINITIONS
Table 1 describes the levels of evidence and the strength 
of recommendations according to the criteria of the Infectious 
Disease Society of America (ISDA)15.
PVC is a catheter shorter than 7.62 cm (3 inches).
Sepsis is a systemic inflammatory response syndrome sec-
ondary to an infection16. The term phlebitis is used if one of 
the following criteria was fulfilled: swelling and erythema > 4 
mm, tenderness, palpable venous cord, pain or fever with local 
symptoms. Isolated swelling is not defined as phlebitis.
INSERTION
1. When?
PVC will be inserted when the duration of a given endo-
venous therapy is expected to be shorter than 6 days and the 
PVC will not be used for major procedures as hemodialysis, plas-
mapheresis, chemotherapy, parenteral nutrition, monitoring or 
administration of fluid large volumes. When any of these cir-
cumstances is to be expected, it is preferable to insert a single-, 
double- or triple-lumen central venous line (peripherally insert-
ed or not) as the risk of chemical phlebitis, the need for high-
speed volume infusion or frequent manipulations do not sup-
port a short catheter (I-A)17,18. An isolated transfusion does not 
need a central venous line insertion. Before placing any venous 
line, even peripheral, it is mandatory the evaluation of the actual 
need. Venous lines are often placed as routine; this meant to be 
an act reflecting the provision of care. It is also frequently shown 
that to treat the patient a “prophylactic” line was not mandato-
ry. A study showed that up to 35% of peripheral venous lines 
place in the emergency department are unnecessary19.
2. Where?
A PVC can be inserted in every accessible vein. However, 
upper extremity veins are preferable for patient comfort and 
lesser risk of contamination. Some studies reported a higher 
risk of phlebitis after lines were placed at the cubital crease, 
thus becoming preferable avoiding this site in benefit of arm, 
forearm or dorsal aspect of the hand/wrist20,21 (II-A).
Furthermore, other patient-related factors like accessibil-
ity to the venous system or comfort after insertion have to be 
taken into account. It does not make much sense to insert a 
PVC onto a central vein (III-A).
3. How?
The insertion of PVC must be performed under maximal 
aseptic techniques. It is not necessary to prep a surgical field 
as it is the when inserting a central venous line. The skin must 
be disinfected with 2% alcoholic chlorhexidine solution or, if 
not available, with a 70% iodine or alcohol solution9,22,23 (I-A). 
The insertion site should not be touched after disinfection. 
The catheter must be handled from its proximal end when in-
serted. The caregiver inserting the PVC must previously perform 
hand hygiene with water and soap and/or wash hands with 
alcohol solution. Single-use clean gloves must be used. An en-
Table 2  Checklist for an appropriate manipulation 
of peripheral catheters. If these are not 
fulfilled, the prompt removal of the 
catheter is advised (Evidence A)
-Insertion
-Correct hand hygiene
-Field disinfection
-Use single-use clean gloves
-Do not touch the insertion site
-Do not touch the endovenous segment of the catheter
-Sterile dressing (gauze or transparent)
-Manipulation
-Daily assessment of the need for the PVC
-Daily inspection of the insertion site
-Daily assessment of the function of the catheter
-Adequate replacement of infusion sets
-Catheter and events registry
-Fluid extravasation
-Presence of blood
-Inflammatory signs
-Dressing status
MAINTENANCE
The catheter and the need for usage have to be assessed 
daily. It is advisable to remove the PVC if it is not necessary 
as the risk of infection or phlebitis gradually increases as PVC 
days go by18,32,33 (II-A). It is advisable to insert new PVC, if re-
quired, than keeping in place an inactive line that might be 
useful at later stage.
The status of the insertion site must also be assessed daily, 
seeking for eventual discomfort/symptoms at the endovascular 
segment suggesting early stages of phlebitis and checking its 
functional status. Phlebitis should be suspected if any of the fol-
lowing signs develop: warmth, tenderness, erythema or palpable 
cord. In an abnormality at the insertion site is detected, dressing 
must be removed and the site inspected34,35 (III-A). The catheter 
must then be removed and its tip sent for Microbiology accord-
ing to the criterion of the attending physician17 (III-A).
No antiseptic cream shall be used at the insertion point36 
(III-C).
Every manipulation of the catheter must be performed 
with single-use clean gloves. There is no consensus on the type 
of connectors to be used. It is preferable a three-way stopcock 
than caps requiring connection-disconnection after every use. 
Closed connectors for catheter access can be used as long as 
they are disinfected with alcohol-impregnated wipes at every 
attempt to access the catheter37 (II-A).
A meta-analysis revealed that there are no advantages of 
replacing the infusion system earlier than 96 hours38,39 (I-A) 
other when they are used for blood transfusion or infusion of 
lipid emulsions (should this be the case, they have to be re-
placed every time). There is no evidence that neither antibiotic 
prophylaxis at insertion nor the antibiotic-lock are cost-effi-
cient to keep PVC free from infection.
REGISTRY
It is mandatory to keep daily record of characteristics and 
conditions of the catheter. In this registry the type of catheter, 
insertion date, anatomic location, daily inspection of dressing, 
removal date and cause of removal (malfunction, infection, 
not required,…) must be recorded (III-A). The lack of a registry 
is synonymous of lack of knowledge on how to use catheters, 
their complications and the inability to establish corrective 
measurements should an event occur40. These registries should 
ideally be electronically supported to facilitated data collection 
and analysis.
REMOVAL
1. When?
As there is a causal relationship between the duration 
of PVC and the risk of phlebitis, the need for systematic re-
placement of PVC at a given time interval to avoid local and 
systemic complications has been proposed18,41,42. However, 
this strategy may render expensive the provision of care by 
increasing in over 25% the cost and number of catheters to 
use and make the catheter resite more difficult42,43. This, on the 
other side, has not avoided the complications of the use of the 
new catheter regardless of the inconveniences of replacing a 
line for the patient and caregiver.
More recently, prospective and randomized studies com-
paring systematic replacement at 72 hours versus clinically 
indicated replacement of PVC did not found statistically signif-
icant differences in the incidence of phlebitis/local infection/
bacteremia and the number of malfunctioning catheters both 
in hospitalized patients and in patients on home therapy18,41-51. 
These observations support the replacement of PVC only when 
indicated (I-A).
Systematic removal of PVC after 3-4 days is not support-
ed, although it is not advised to keep PVC in place beyond 5 
days (III-B).
Although keeping in place an unused catheter increases 
the risk of phlebitis51, it is not clear if they must be rinsed with 
normal saline or heparin. It seems that the risk of phlebitis is 
reduced with heparin but it continues to be at 45%52, thus be-
ing removal advisable if unused. Therefore, unused catheters 
should not be kept in place as the risk of inflammation and 
infection increases10,53-55 (I-A).
PVC must be removed if the following circumstances ap-
ply: end of therapy, signs of chemical phlebitis, malfunction, 
suspicion of infection or suspicion of inappropriate insertion 
or manipulation as in cases of vital emergency56,57 (II-A).
2. How?
Simple removal will be performed with single-use clean 
gloves and gauze dressing applied thereafter. Removal for sus-
pected infection implies sending the tip of the catheter (2-3 
mm of distal end) in a sterile container for Microbiology. In the 
latter case, single-use sterile gloves and sterile instrument to 
cut the tip of the PVC must be used. Only catheters with sus-
pected infection must be sent for Microbiology (III-A). There 
will be suspected infection if fever or signs of sepsis without 
evident focus and/or suppurated phlebitis appeared. Chemical 
phlebitis alone is not enough to submit the catheter for Mi-
crobiology. It has to be reminded that catheter-related bac-
teremia may develop without any suspicion that the catheter 
may be the cause8,58.
DIAGNOSIS
PVC infection shall be suspected when a patient with one 
or more PVC develops fever and/or signs of sepsis without ad-
ditional clinical focus. Under this circumstance, past history of 
inappropriate manipulation and prolonged duration support a 
PVC-suspected origin of infection. Septic phlebitis or suppura-
tion at the insertion site support this hypothesis58,59; however 
simple chemical phlebitis may cause low-grade fever.
If infection is suspected, 2-3 samples for blood culture 
must be collected. Sampling from PVC must be performed un-
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der aseptic conditions. A cotton swab should be used to take 
samples from purulent exudate if present. As PVCs should be 
of short duration and of easy replacement it is not justified to 
keep a catheter in situ while awaiting results from Microbiol-
ogy if infection is suspected (III-B). We then believe that con-
servative diagnostic techniques for diagnosis of infection are 
not applicable60,61 (III-A). Gram stain of a PVC segment may 
quickly draw the attention on the possibility of infection62.
TREATMENT
In the treatment of PVC infection, the first step is re-
moval of the PVC as it has been mentioned above. Once the 
PVC is removed and blood samples taken for culture, the 
need for empirical antibiotic treatment will be related to 
the clinical condition of the patient (including fever and el-
evation of biomarkers). Treatment should be directed to PVC 
bacteremia. Isolated positive tips cultures don´t need antibi-
otic treatment. 
If empirical antibiotic treatment is initiated, Gram-positive 
cocci (including methicillin-resistant S. aureus) and Gram-neg-
ative bacilli (including P. aeruginosa) must be addressed ac-
cording to individual patient risk factors and the institutional 
flora. Other possible etiologies, albeit infrequent, have to be 
considered in special subsets of patients as those previously 
treated with antibiotics, with multiple comorbidities, immune 
depressed or hospitalized for long periods of time63. S. aureus 
has become an increasingly impactful etiologic pathogen for 
bacteremia as it has been shown in several studies3,4,64-66. For 
bacteremia related to central venous catheters, the etiology is 
well diversified.
A reasonable empirical regimen is a combination of dap-
tomycin and a ß-lactam active against P. aeruginosa. In pa-
tients with ß-lactam allergies, aztreonam, an aminoglycoside 
or a quinolone could be an alternative. In any case, treatment 
should follow sensitivity patterns at 24-72 hours after cultures 
are taken67,68 (I-A).
The duration of antibiotic treatment will be related to the 
isolated pathogen. S. epidermidis can be treated with removal 
of PVC if no other inert material that can be colonized and/
or infected exists; duration of treatment should not be longer 
than 7 days. If no antibiotic treatment is given, the patient 
must be symptom-free and cultures must be negative upon 
removal of PVC.
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Table 3  Summary of recommendations and degree of evidence (see table 1).
Always assess the need of inserting a catheter. If necessary, a central venous line should be preferred over a PVC if duration of intravenous treatment  
longer than 6 days or blood transfusion, parenteral nutrition or chemotherapy I-A17,18
If possible, PVC should not be placed in the lower extremities or at the elbow crease due to higher risk of phlebitis II-A20,21
Insertion of PVC must be performed with the maximum hygiene with no need for a surgical field. 
There are no preferences as to which disinfectant solution to use I-A9,22,23
An sterile dressing must be used to cover the insertion site (gauze dressing or transparent semi permeate) II-A24,25
Adherence to pre-insertion checklist improves prevention of complication outcomes I-A10,31
The need for PVC should be assessed on daily basis. If it is not necessary, it is advisable to remove the PVC II-A18,32,33
The insertion site must be inspected daily. If abnormalities, malfunction or discomfort at the subcutaneous site, PVC should be removed III-A17,34-35
No antiseptic cream/gel should be used at the insertion site III-C36
Closed connectors to access the PVC can be used; its external surface must always be decontaminated II-A37
Infusion sets can be utilized up to 96 hours, exception made of blood transfusion or lipid emulsions I-A38,39
It is mandatory that the nursing files a daily record of the PVC III-A40
It is not advisable to remove PVC on a routine basis. PVC should be replaced when clinically indicated I-A18,41-51
It is advisable not to keep a PVC in place for over 5 days III-B
Unused catheters must be removed II-A10,53,55
When there is suspicion of PVC inserted under suboptimal conditions, it must be removed III-A56,57
If there is suspicion of infection, it is not indicated to use diagnostic technique leaving the PVC in place III-A
If there is a suspicion of catheter-related infection, the tip of the PVC must be submitted for Microbiology.  
Removed PVC non suspected to be infected not need Microbiology III-A
Empiric antibiotic treatment of PVC-related bacteremia has to be deescalated according to microbiology results I-A67,68
Continuous education in insertion and maintenance guidelines is an appropriate way to reduce complications I-A74-87
A different situation is S. aureus or C. albicans infection 
as those require a minimum of 14 days of treatment69 and fol-
low-up cultures at 72 hours. Secondary infectious foci like en-
docarditis and/or osteomyelitis must be ruled out70. This is even 
more important if bacteremia persists after removal of the PVC 
thus indicating a more prolonged presence of bacteria in the 
blood stream70-73. This Consensus Document does not pretend 
reviewing the treatment of S. aureus or other bacteremias and 
the reader is referred to specific guidelines70,71. Gram-negative 
bacilli infections usually need 7 to 14 days of treatment after 
removal of PVC and after the first negative blood culture is 
confirmed7.
CONTINUOUS EDUCATION
Continuous education of healthcare caregivers on the 
indications for PVC insertion and the convenience of having 
PVC inserted is necessary. It is necessary to periodically re-
mind the nursing staff inserting PVC the guidelines for in-
sertion and maintenance74-81 (I-A).  Table 3 summarizes the 
recommendations and degree of evidence and references as 
produced in this document. The lack of a continuous edu-
cation programme leads to relaxation of the norm, aban-
donment of good clinical practices and increase in infection 
and complication rates. On the contrary, specific educational 
programmes help in reducing infection rates82-87. There are 
different ways to provide education. Education among peers 
has shown the best benefits in guideline follow-up as the 
staff is engaged in education.
It is advisable that the infection and complication rates 
are periodically disclosed to the staff in charge of inserting 
PVCs. This is positive reinforcement on guideline/protocol fol-
low-up and a warning if deviations occur. Furthermore, the 
adherence to the checklist can be monitored (table 2).
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